Allworth Financial’s Day One Biopharmaceuticals DAWN Stock Holding History

Allworth Financial’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,002	Closed	-$21.5K	–	5209
2026 Q1	$21.5K	Buy	1,002 +810	+422%	+$11.4K	﹤0.01%	2941
2025 Q4	$1.79K	Buy	192 +66	+52%	+$551	﹤0.01%	4164
2025 Q3	$889	Sell	126 -4	-3%	-$28	﹤0.01%	4288
2025 Q2	$845	Buy	130 +107	+465%	+$736	﹤0.01%	4003
2025 Q1	$182	Buy	23 +17	+283%	+$183	﹤0.01%	3890
2024 Q4	$75	Hold	6	–	–	﹤0.01%	3856
2024 Q3	$84	Buy	+6	New	+$86	﹤0.01%	3666

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allworth Financial's DAWN Position: Q2 2026 in Review

Allworth Financial sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,002 shares — an estimated $21.5K sold.

Allworth Financial first reported a position in DAWN in Q3 2024 and held it in 7 quarters. The position peaked at $21.5K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Allworth Financial reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Allworth Financial sold 1,002 Day One Biopharmaceuticals shares in Q2 2026, an estimated $21.5K.
Allworth Financial first reported a position in Day One Biopharmaceuticals in Q3 2024 and held it in 7 quarters.
Allworth Financial's Day One Biopharmaceuticals position peaked at $21.5K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.